Robinhood investors are known for their capricious and sometimes idiosyncratic trading activity, but it would be folly to discount their growing effect on the price of small-cap stocks. Especially for nascent or clinical-stage biotech companies without any products approved for sale, a spurt of growth prompted by a favorable report of preliminary clinical trial data can easily explode into a massive rally once Robinhood traders get wind of it.
Thus, investors interested in profiting from the movement of the Robinhood army should keep an eye on a few key stocks that are already popular on the platform -- if only to put to rest the fear of missing out.
Image source: Getty Images.